60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.130
0.00 (0.00%)
At close: Aug 21, 2026, 4:00 PM EDT
1.114
-0.016 (-1.43%)
After-hours: Aug 21, 2026, 7:39 PM EDT
60 Degrees Pharmaceuticals Employees
60 Degrees Pharmaceuticals had 3 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$404,977
Profits / Employee
-$2,874,812
Market Cap
3.00M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3 | 0 | - |
| Dec 31, 2024 | 3 | 0 | - |
| Dec 31, 2023 | 3 | 1 | 50.00% |
| Dec 31, 2022 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| HCW Biologics | 35 |
| Calidi Biotherapeutics | 29 |
| Virax Biolabs Group | 26 |
| Curis | 24 |
| Genprex | 13 |
| Artelo Biosciences | 7 |
| Galmed Pharmaceuticals | 6 |
SXTP News
- 8 days ago - 60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results - GlobeNewsWire
- 9 days ago - 60 Degrees Pharmaceuticals Registration statement: Registration filing - Filings
- 9 days ago - 60 Degrees Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 9 days ago - 60 Degrees Pharmaceuticals Earnings release: Q2 2026 - Filings
- 23 days ago - 60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 24 days ago - 60 Degrees Pharmaceuticals Announces Minimum Enrollment Achieved in Hospitalized Babesiosis Study; Interim Data Readout Planned by October 6, 2026 - GlobeNewsWire
- 6 weeks ago - 60 Degrees Pharmaceuticals Announces Exclusive Option Agreement with Florida State University to Advance Castanospermine for Tick-Borne Diseases - GlobeNewsWire
- 7 weeks ago - 60 Degrees Pharmaceuticals Proxy statement: Proxy filing - Filings